The prevalence of seizures in children with developmental delay

Raidah Albaradie1, Hafiz Habibullah1, Ali Mir1

  • 1From the Department of Pediatric neurology (Albaradie, Habibullah, Mir), Neuroscience Center (Bashir), King Fahad Specialist Hospital, Dammam, from the College of Medicine (Alshammari, Alajmi, Alsubaie, Alsudairi), Imam Abdulrahman Bin Faisal University, Dammam, Kingdom of Saudi Arabia.

Insights

Epilepsy is common in children with global developmental delay (GDD). Advanced paternal age and seizure type are key factors associated with epilepsy in this population.

Area of Science:

  • Pediatric Neurology
  • Developmental Pediatrics
  • Clinical Epidemiology

Background:

  • Global developmental delay (GDD) is a significant concern in pediatric neurology.
  • The co-occurrence of epilepsy in children with GDD requires further investigation.
  • Understanding risk factors for epilepsy in GDD is crucial for early intervention.

Purpose of the Study:

  • To determine the prevalence of epilepsy in children diagnosed with GDD.
  • To identify patient characteristics associated with epilepsy in GDD.
  • To examine the influence of risk factors on the GDD-epilepsy association.

Main Methods:

  • Retrospective cross-sectional study design.
  • Data collected from electronic medical records of 200 pediatric patients with GDD.
  • Study conducted at King Fahad Specialist Hospital, Saudi Arabia.

Main Results:

  • Epilepsy prevalence was 56% among children with GDD.
  • Generalized onset motor seizures were the most common type (37.5%).
  • Advanced paternal age was significantly associated with epilepsy (p=0.003).

Conclusions:

  • High prevalence of epilepsy in children with GDD highlights a critical clinical issue.
  • Advanced paternal age and specific seizure types are significant factors in the GDD-epilepsy correlation.
  • Further research is warranted to explore the complex relationship between GDD and epilepsy.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
792
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
893
Learning Disabilities01:25

Learning Disabilities

Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
359
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
580
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
275